Evidence map›Paper›PMID 35429790›Full record

ReviewJournal of infection and public health2022

SARS-CoV-2 vaccines: Clinical endpoints and psychological perspectives: A literature review.

Jonaid Ahmad Malik, Mir Aroosa, Sakeel Ahmed, Mrunal Shinde, Saleh Alghamdi, Khaled Almansour, Turki Al Hagbani, Muteb Sultan Alanazi, Sirajudheen Anwar

Abstract readReview
In one paragraph

Review in Journal of infection and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jonaid Ahmad MalikDepartment of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Guwahati, India; Department of Biomedical Engineering, Indian Institute of Technology Ropar, Rupnagar Punjab, India.
Mir AroosaDepartment of Pharmacology, Jamia Hamdard, New Delhi, India.
Sakeel AhmedDepartment of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Ahmedabad, India.
Mrunal ShindeDepartment of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research, Guwahati, India.
Saleh AlghamdiDepartment of Clinical Pharmacy, Faculty of Clinical Pharmacy, Al Baha University, Al Baha, Saudi Arabia.
Khaled AlmansourDepartment of Pharmaceutics, College of Pharmacy, University of Hail, Hail, Saudi Arabia.
Turki Al HagbaniDepartment of Pharmaceutics, College of Pharmacy, University of Hail, Hail, Saudi Arabia.
Muteb Sultan AlanaziDepartment of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia.
Sirajudheen AnwarDepartment of Pharmacology, College of Pharmacy, University of Hail, Hail, Saudi Arabia. Electronic address: si.anwar@uoh.edu.sa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAbout 270 million cases have been confirmed, and 5.3 million fatalities Worldwide due to SARS-CoV-2. Several vaccine candidates have entered phase 3 of the clinical trial and are being investigated to provide immunity to the maximum percentage of people. A safe and effective vaccine is required to tackle the current COVID-19 waves. There have been reports that clinical endpoints and psychological parameters are necessary to consider vaccine efficacy. This review examines the clinical endpoints required for a successful SARS-CoV-2 vaccine and the influences of psychological parameters on its efficacy.

methodsThe main research question was to find out the clinical endpoints that determine the vaccine efficacy? And what kind of psychological parameters affect the vaccine efficacy? The information was taken from several journals, databases, and scientific search engines like Googe scholar, Pubmed, Scopus, Web of Science, Science direct, WHO website, and other various sites. The research studies were searched using keywords; SAR-CoV-2 vaccine efficacy, psychological effect on SARS-CoV-2 vaccine, SARS-CoV-2 vaccine endpoints.

resultsThis review has highlighted various clinical endpoints that are the main determinants of clinical vaccine efficacy. Currently, vaccinations are being carried out throughout the world; it is important to investigate the main determinants affecting vaccine efficacy. We have focused on the clinical endpoints and the influence of psychological parameters that affect the vaccine efficacy in clinical settings. The primary endpoints include the risk of infection, symptoms, and severity of COVID-19, while hospitalization length, supplemental oxygen requirement, and mechanical ventilation are secondary endpoints in the clinical endpoints. Some tangential endpoints were also considered, including organ dysfunction, stroke, and MI. Many psychological associated things have influenced the vaccine efficacy, like the lower antibody titers in the vaccinated people. In addition to that, Short- and long-term stress and sleep deprivation were also found to affect the vaccine efficacy.

conclusionThe review summarizes the important clinical endpoints required for a successful vaccine candidate. In addition to primary and secondary endpoints, auxiliary endpoints and the disease burden also play an important role in modulating vaccine efficacy. Moreover, the psychological perspective also influences vaccine efficacy. Effective follow-up of participants should follow to examine the clinical endpoints to reach any conclusion about vaccine efficacy.

Indexed as

COVID-19VaccinesCOVID-19 VaccinesHumansRespiration, ArtificialSARS-CoV-2COVID-19 VaccinesVaccinesClinical endpointsPsychological effectSARS-CoV-2Vaccine efficacy

Identifiers

PMID35429790
PMCPMC8969448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.